Rhiannon White
CEO
Clue
Clue provides a mobile‑first platform for tracking menstrual, ovulatory and reproductive health data, using AI‑enhanced models to forecast periods, ovulation, fertile windows and symptom trends. The app offers a free core tracker and a subscription‑based Clue Plus tier with advanced analytics, expert content, and secure data sharing with partners or clinicians, while anonymized data support research on female health conditions.
Updated 2 days ago
Funding
Raised to date
$9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+1Funding rounds are not available yet.
Founders
Ida Tin
Co-Founder
Product
Problem
Many people who menstruate lack a reliable, science‑backed tool to consistently log cycle data, receive personalized health insights, and safely share information with partners or clinicians. Existing solutions often provide limited predictions, inadequate privacy safeguards, and do not contribute data to improve research on under‑studied female health conditions.
Solution
Clue offers a mobile‑first platform that records menstrual, ovulatory, and reproductive health metrics across iOS, Android, and watchOS devices. The app applies data‑driven algorithms to generate cycle forecasts, symptom trends, and fertility windows tailored to each user’s history. Users can switch between dedicated tracking modes for trying to conceive, pregnancy, and perimenopause, ensuring relevance throughout life stages. A premium subscription, Clue Plus, unlocks deeper pattern analysis, expert‑curated content, and the ability to share selected data with partners via Clue Connect. All data are anonymized and aggregated to support research collaborations with academic institutions, while strict GDPR‑compliant safeguards protect user privacy.
Target Audience
The primary users are individuals who menstruate and seek accurate, personalized cycle tracking—including those trying to conceive, pregnant, or navigating perimenopause—as well as clinicians who benefit from aggregated health insights.
Features
- CE‑marked Class 1 medical‑grade device with clinically validated hormone cycle models
- AI‑enhanced predictions for period start, ovulation, fertile window, and symptom severity
- Mode‑specific tracking (standard cycle, conception, pregnancy, perimenopause) with customizable symptom logs
- Clue Plus premium analytics: advanced pattern detection, long‑term trend visualizations, and medical‑expert content library
- Clue Connect secure sharing of selected cycle data with partners or healthcare providers
- Seamless integration with major wearables for automatic heart‑rate and activity data import
- Anonymized data contribution pipeline enabling research on endometriosis, PCOS, PMDD, and other conditions
- End‑to‑end encryption and GDPR‑aligned data management, with user‑controlled export and deletion options